单细胞分析揭示CRLF2重排是唐氏综合征和非唐氏综合征急性淋巴细胞白血病中的早期和晚期事件
研究旨在确定CRLF2重排(IGH-CRLF2或P2RY8-CRLF2)在唐氏综合征急性淋巴细胞白血病(DS-ALL)和非DS-ALL演化中发生的时间。利用荧光原位杂交追踪47例CRLF2重排B-ALL患者单细胞中最多四种结构变异,并对另外4例患者进行多重单细胞分析,同时追踪拷贝数变异、结构和单核苷酸变异。观察到CRLF2重排作为早期和晚期事件发生,存在平行演化及线性与分支演化,DS-ALL早期克隆携带包括CRLF2重排在内的多种异常。
要点
- CRLF2重排在DS-ALL和非DS-ALL中均可作为早期或晚期事件出现。
- CRLF2重排B-ALL发展过程中可观察到离散克隆的平行演化。
- 单细胞分析显示线性和分支演化,DS-ALL早期克隆携带多种异常包括CRLF2重排。
核心结论
- CRLF2重排在唐氏综合征和非唐氏综合征B-ALL中均作为早期和晚期事件发生,并伴有克隆的平行、线性和分支演化。
研究设计与样本
- 研究采用荧光原位杂交追踪47例CRLF2重排B-ALL患者单细胞中最多四种结构变异,并对另外4例患者进行多重单细胞分析。
主要发现
- 在DS-ALL和非DS-ALL患者中均观察到CRLF2重排作为早期和晚期事件发生。
- 在CRLF2重排B-ALL发展过程中观察到离散克隆的平行演化,涉及CRLF2重排或其他追踪到的异常。
- 深入单细胞分析识别出线性和分支演化,DS-ALL患者的早期克隆携带多种异常,包括CRLF2重排。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Deregulated expression of the type I cytokine receptor, CRLF2, is observed in 5-15% of precursor B-cell acute lymphoblastic leukaemia (B-ALL). We have previously reported the genomic landscape of patients with CRLF2 rearrangements (CRLF2-r) using both whole genome and exome sequencing, which identified a number of potential clonal and sub-clonal genomic alterations. In this study, we aimed to assess when the CRLF2-r; IGH-CRLF2 or P2RY8-CRLF2, arose during the evolution of both Down syndrome-ALL (DS-ALL) and non-DS-ALL. Using fluorescence in situ hybridisation, we were able to track up to four structural variants in single cells from 47 CRLF2-r B-ALL patients, which in association with our multiplex single-cell analysis of a further four patients, permitted simultaneous tracking of copy number alterations, structural and single nucleotide variants within individual cells. We observed CRLF2-r arising as both early and late events in DS and non-DS-ALL patients. Parallel evolution of discrete clones was observed in the development of CRLF2-r B-ALL, either involving the CRLF2-r or one of the other tracked abnormalities. In-depth single-cell analysis identified both linear and branching evolution with early clones harbouring a multitude of abnormalities, including the CRLF2-r in DS-ALL patients.
引用
- Potter N, Jones L, Blair H, et al. Single-cell analysis identifies CRLF2 rearrangements as both early and late events in Down syndrome and non-Down syndrome acute lymphoblastic leukaemia. Leukemia. 2018. PMID: 30487598. doi:10.1038/s41375-018-0297-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。